These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Novel pyrazolo[3,4-d]pyrimidine with 4-(1H-benzimidazol-2-yl)-phenylamine as broad spectrum anticancer agents: Synthesis, cell based assay, topoisomerase inhibition, DNA intercalation and bovine serum albumin studies. Singla P; Luxami V; Singh R; Tandon V; Paul K Eur J Med Chem; 2017 Jan; 126():24-35. PubMed ID: 27744184 [TBL] [Abstract][Full Text] [Related]
12. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells. Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, molecular modeling and biological evaluation of new benzo[4,5]thieno[3,2-b]pyran derivatives as topoisomerase I-DNA binary complex poisons. Ahmed EM; Khalil NA; Zaher AF; Alhamaky SM; El-Zoghbi MS Bioorg Chem; 2021 Jul; 112():104915. PubMed ID: 33905973 [TBL] [Abstract][Full Text] [Related]
14. 1,2,3-Triazole Tagged 3H-Pyrano[2,3-d]pyrimidine-6-carboxylate Derivatives: Synthesis, in Vitro Cytotoxicity, Molecular Docking and DNA Interaction Studies. Boda SK; Pishka V; Lakshmi PVA; Chinde S; Grover P Chem Biodivers; 2018 Jun; 15(6):e18000101. PubMed ID: 29660245 [TBL] [Abstract][Full Text] [Related]
15. Novel diindoloazepinone derivatives as DNA minor groove binding agents with selective topoisomerase I inhibition: Design, synthesis, biological evaluation and docking studies. Kadagathur M; Devi GP; Grewal P; Sigalapalli DK; Makhal PN; Banerjee UC; Bathini NB; Tangellamudi ND Bioorg Chem; 2020 Jun; 99():103629. PubMed ID: 32272367 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, Molecular Docking Study and in vitro Anticancer Activity of Tetrazole Linked Benzochromene Derivatives. Gorle S; Maddila S; Maddila SN; Naicker K; Singh M; Singh P; Jonnalagadda SB Anticancer Agents Med Chem; 2017; 17(3):464-470. PubMed ID: 27357544 [TBL] [Abstract][Full Text] [Related]
17. Topo II inhibition and DNA intercalation by new phthalazine-based derivatives as potent anticancer agents: design, synthesis, anti-proliferative, docking, and Khalifa MM; Al-Karmalawy AA; Elkaeed EB; Nafie MS; Tantawy MA; Eissa IH; Mahdy HA J Enzyme Inhib Med Chem; 2022 Dec; 37(1):299-314. PubMed ID: 34894955 [TBL] [Abstract][Full Text] [Related]
18. Design and Discovery of Novel Quinoxaline Derivatives as Dual DNA Intercalators and Topoisomerase II Inhibitors. Eissa IH; El-Naggar AM; El-Sattar NEAA; Youssef ASA Anticancer Agents Med Chem; 2018; 18(2):195-209. PubMed ID: 28699490 [TBL] [Abstract][Full Text] [Related]
19. Studies on 1,4-Quinone Derivatives Exhibiting Anti-Leukemic Activity along with Anti-Colorectal and Anti-Breast Cancer Effects. Ciftci H; Sever B; Kaya N; Bayrak N; Yıldız M; Yıldırım H; Tateishi H; Otsuka M; Fujita M; TuYuN AF Molecules; 2022 Dec; 28(1):. PubMed ID: 36615273 [TBL] [Abstract][Full Text] [Related]